McKesson Co. (NYSE:MCK) Chairman John H. Hammergren sold 65,000 shares of McKesson stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $160.00, for a total transaction of $10,400,000.00. The sale was disclosed in a document filed with the SEC, which is available at this link.
John H. Hammergren also recently made the following trade(s):
- On Friday, September 22nd, John H. Hammergren sold 225,000 shares of McKesson stock. The shares were sold at an average price of $151.67, for a total transaction of $34,125,750.00.
- On Wednesday, September 20th, John H. Hammergren sold 125,000 shares of McKesson stock. The shares were sold at an average price of $150.18, for a total transaction of $18,772,500.00.
- On Friday, September 22nd, John H. Hammergren sold 100,000 shares of McKesson stock. The stock was sold at an average price of $153.53, for a total transaction of $15,353,000.00.
Shares of McKesson Co. (NYSE:MCK) traded up $1.63 during mid-day trading on Thursday, reaching $162.30. 1,538,177 shares of the company’s stock traded hands, compared to its average volume of 1,452,234. The company has a market capitalization of $33,840.00, a price-to-earnings ratio of 7.69, a price-to-earnings-growth ratio of 1.61 and a beta of 1.23. The company has a current ratio of 1.05, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. McKesson Co. has a twelve month low of $133.82 and a twelve month high of $169.29.
McKesson (NYSE:MCK) last announced its quarterly earnings data on Thursday, October 26th. The company reported $3.28 EPS for the quarter, topping the consensus estimate of $2.78 by $0.50. McKesson had a net margin of 2.24% and a return on equity of 24.87%. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.69 billion. During the same quarter in the previous year, the firm posted $2.94 earnings per share. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. analysts expect that McKesson Co. will post 12.23 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Friday, December 1st were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.84%. The ex-dividend date was Thursday, November 30th. McKesson’s dividend payout ratio (DPR) is currently 6.44%.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. raised its position in shares of McKesson by 8.0% in the second quarter. BlackRock Inc. now owns 15,330,001 shares of the company’s stock valued at $2,522,396,000 after purchasing an additional 1,131,024 shares during the period. Vanguard Group Inc. raised its position in shares of McKesson by 0.4% in the second quarter. Vanguard Group Inc. now owns 14,090,544 shares of the company’s stock valued at $2,318,457,000 after purchasing an additional 62,004 shares during the period. Bank of New York Mellon Corp raised its position in shares of McKesson by 6.5% in the third quarter. Bank of New York Mellon Corp now owns 2,540,305 shares of the company’s stock valued at $390,217,000 after purchasing an additional 154,967 shares during the period. Pzena Investment Management LLC raised its position in shares of McKesson by 17.2% in the third quarter. Pzena Investment Management LLC now owns 2,458,531 shares of the company’s stock valued at $377,655,000 after purchasing an additional 360,676 shares during the period. Finally, Wells Fargo & Company MN raised its position in shares of McKesson by 12.7% in the second quarter. Wells Fargo & Company MN now owns 2,121,171 shares of the company’s stock valued at $349,017,000 after purchasing an additional 239,358 shares during the period. 87.88% of the stock is currently owned by institutional investors.
Several research analysts recently weighed in on MCK shares. Robert W. Baird upgraded shares of McKesson from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $175.00 to $178.00 in a report on Tuesday, September 19th. Mizuho set a $168.00 price target on shares of McKesson and gave the stock a “hold” rating in a report on Tuesday, October 24th. ValuEngine upgraded shares of McKesson from a “hold” rating to a “buy” rating in a report on Tuesday, October 31st. Credit Suisse Group restated an “underperform” rating and set a $130.00 price target (down from $155.00) on shares of McKesson in a report on Thursday, November 9th. Finally, Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $177.00 price target on the stock in a report on Tuesday, December 26th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $174.64.
ILLEGAL ACTIVITY WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/11/john-h-hammergren-sells-65000-shares-of-mckesson-co-mck-stock.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.